Related references
Note: Only part of the references are listed.Engineered off-the-shelf therapeutic T cells resist host immune rejection
Feiyan Mo et al.
NATURE BIOTECHNOLOGY (2021)
Multipathogen-specific T cells against viral and fungal infections
Anastasia Papadopoulou et al.
BONE MARROW TRANSPLANTATION (2021)
Cerberus T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients
Kiriakos Koukoulias et al.
FRONTIERS IN IMMUNOLOGY (2021)
Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi
Stanislaw Schmidt et al.
JOURNAL OF FUNGI (2021)
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
Xiaoyan Wu et al.
MICROBIOME (2021)
Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant
David Jonathan Gottlieb et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections
Spyridoula Vasileiou et al.
HAEMATOLOGICA (2020)
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
Susan Prockop et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Aspergillus fumigatus Infection in Humans With STAT3-Deficiency Is Associated With Defective Interferon-Gamma and Th17 Responses
Francois Danion et al.
FRONTIERS IN IMMUNOLOGY (2020)
Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis
Amy I. Yu et al.
CELL REPORTS (2020)
Complete clinical remission of invasive Candida infection with CARD9 deficiency after G-CSF treatment
Bailu Du et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2020)
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells
Rafet Basar et al.
BLOOD ADVANCES (2020)
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity
Gloria Castellano-Gonzalez et al.
BLOOD ADVANCES (2020)
CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation
Theresa Kaeuferle et al.
MOLECULAR THERAPY (2020)
Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
Corey Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Using Expanded Natural Killer Cells as Therapy for Invasive Aspergillosis
Win Mar Soe et al.
JOURNAL OF FUNGI (2020)
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial
Corey Smith et al.
CLINICAL INFECTIOUS DISEASES (2019)
Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host
Anastasia Papadopoulou et al.
BONE MARROW TRANSPLANTATION (2019)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Petra Bacher et al.
CELL (2019)
Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease
Sajida Kazi et al.
HAEMATOLOGICA (2019)
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Theresa Kaeuferle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The Still Underestimated Problem of Fungal Diseases Worldwide
Fausto Almeida et al.
FRONTIERS IN MICROBIOLOGY (2019)
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
Wei Jiang et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
A novel approach to candidemia? The potential role of checkpoint inhibition
Sibylle C. Mellinghoff et al.
MEDICAL MYCOLOGY (2019)
Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation
Giorgio Ottaviano et al.
CELLS (2019)
The use of granulocyte colony stimulating factor after autologous hematopoietic stem cell transplantation
F. Farkas et al.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2019)
Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients
Allistair A. Abraham et al.
BLOOD ADVANCES (2019)
The Candida auris Alert: Facts and Perspectives
Frederic Lamoth et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae
Paul Castillo et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy
Muharrem Muftuoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections
Sarah Delliere et al.
JOURNAL OF FUNGI (2018)
Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT
C. Qian et al.
BONE MARROW TRANSPLANTATION (2018)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
David Grimaldi et al.
LANCET INFECTIOUS DISEASES (2017)
Virus-Specific T Cells for the Immunocompromised Patient
Amy Houghtelin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Modulating host immune responses to fight invasive fungal infections
James E. Scriven et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
Fungal Strategies to Evade the Host Immune Recognition
Marco J. Hernandez-Chavez et al.
JOURNAL OF FUNGI (2017)
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
Barbara Withers et al.
BLOOD ADVANCES (2017)
Fungal dysbiosis: immunity and interactions at mucosal barriers
Iliyan D. Iliev et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Granulocyte transfusions in the management of invasive fungal infections
Kamille A. West et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Invasive Fungal Infection in Primary Immunodeficiencies Other Than Chronic Granulomatous Disease
A. Garraffo et al.
CURRENT FUNGAL INFECTION REPORTS (2017)
Virus-specific T-cell therapy in solid organ transplantation
Andy Roemhild et al.
TRANSPLANT INTERNATIONAL (2016)
T cells for viral infections after allogeneic hematopoietic stem cell transplant
Catherine M. Bollard et al.
BLOOD (2016)
Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges
Anastasia Papadopoulou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells
Shivashni S. Deo et al.
CYTOTHERAPY (2016)
Successful Granulocyte Colony-stimulating Factor Treatment of Relapsing Candida albicans Meningoencephalitis Caused by CARD9 Deficiency
Fatih Celmeli et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia
Yvonne Schmiedel et al.
SWISS MEDICAL WEEKLY (2016)
Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
Justyna Ogonek et al.
FRONTIERS IN IMMUNOLOGY (2016)
T cells from patients with Candida sepsis display a suppressive immunophenotype
Andrej Spec et al.
CRITICAL CARE (2016)
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
Laurie Menger et al.
BLOOD (2015)
Antifungal T-cells progress in manufacture and prospects for the clinic
David Gottlieb
CYTOTHERAPY (2015)
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation
Chun K. K. Ma et al.
CYTOTHERAPY (2015)
Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer
Petra Bacher et al.
CYTOTHERAPY (2015)
Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial
Liping Wan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Heather R. Conti et al.
JOURNAL OF IMMUNOLOGY (2015)
Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis
Claudia Stuehler et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
How to bolster the antifungal pipeline
David W. Denning et al.
SCIENCE (2015)
Cytomegalovirus Infection and Memory T Cell Inflation
Jihye Kim et al.
Immune Network (2015)
Multispecific Aspergillus T Cells Selected by CD137 or CD154 Induce Protective Immune Responses Against the Most Relevant Mold Infections
Claudia Stuehler et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Adoptive T-cell therapy for fungal infections in haematology patients
Shivashni S. Deo et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
Corine E. Delsing et al.
BMC INFECTIOUS DISEASES (2014)
G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent
Linda J. Bendall et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells: Lessons From a Phase I/II Feasibility and Safety Study
Geraldine Gallot et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Systemic Inflammatory Response Syndrome After Administration of Unmodified T Lymphocytes
Anastasia Papadopoulou et al.
MOLECULAR THERAPY (2014)
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
Pappanaicken R. Kumaresan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
Anastasia Papadopoulou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Colony-stimulating factors for chemotherapy-induced febrile neutropenia
Rahul Mhaskar et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
Emily Blyth et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes
Lars Tramsen et al.
CYTOTHERAPY (2013)
Characterization of the T-Cell-Mediated Immune Response Against the Aspergillus fumigatus Proteins Crf1 and Catalase 1 in Healthy Individuals
Hetty Jolink et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2013)
Tacrolimus Inhibits NF-κB Activation in Peripheral Human T Cells
Ramin Vafadari et al.
PLOS ONE (2013)
Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis
Katherine C. Chang et al.
CRITICAL CARE (2013)
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial
Joseph N. Jarvis et al.
AIDS (2012)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Th17 Cells in Immunity to Candida albicans
Nydiaris Hernandez-Santos et al.
CELL HOST & MICROBE (2012)
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Michael Uhlin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus
Shivashni S. Gaundar et al.
CYTOTHERAPY (2012)
Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+T cells against Aspergillus fumigatus infection
Z. Sun et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Characterization of the Cellular Immune Responses to Rhizopus oryzae With Potential Impact on Immunotherapeutic Strategies in Hematopoietic Stem Cell Transplantation
Stanislaw Schmidt et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2012)
Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens
Joshua D. Nosanchuk et al.
FRONTIERS IN MICROBIOLOGY (2012)
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154
Nina Khanna et al.
BLOOD (2011)
Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans
Claudia Stuehler et al.
BLOOD (2011)
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient
A. Balduzzi et al.
BONE MARROW TRANSPLANTATION (2011)
Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia
Stanislaw Schmidt et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2010)
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up
Tanzina Haque et al.
TRANSPLANTATION (2010)
Th17 cytokines in mucosal immunity and inflammation
Lokesh Guglani et al.
CURRENT OPINION IN HIV AND AIDS (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy
L. Tramsen et al.
BONE MARROW TRANSPLANTATION (2009)
Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
Antonella Torosantucci et al.
PLOS ONE (2009)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
Thomas Widmann et al.
PLOS ONE (2008)
Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses
F. Zhu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
An anti-β-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo
Anna Rachini et al.
INFECTION AND IMMUNITY (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant
Lars Tramsen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
T Feuchtinger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
J Pachl et al.
CLINICAL INFECTIOUS DISEASES (2006)
Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus
O Beck et al.
BLOOD (2006)
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation
K Perruccio et al.
BLOOD (2005)
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
RA Larsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
PG Pappas et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Generation of Aspergillus- and CMV-specific T-cell responses using autologous fast DC
G Ramadan et al.
CYTOTHERAPY (2004)
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation
S Bozza et al.
BLOOD (2003)
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
KS Peggs et al.
LANCET (2003)
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
M Hakki et al.
BLOOD (2003)
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation
RA Seder et al.
NATURE IMMUNOLOGY (2003)
Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine
XY Zhan et al.
TRANSPLANTATION (2003)
Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis
AP Campanelli et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
T cells down-modulate peptide-MHC complexes on APCs in vivo
RM Kedl et al.
NATURE IMMUNOLOGY (2002)
Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients
B Savoldo et al.
TRANSPLANTATION (2001)
Assessing risk factors for systemic fungal infections
J Maertens et al.
EUROPEAN JOURNAL OF CANCER CARE (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Granulocyte colony-stimulating factor and other cytokines in antifungal therapy
F Roilides et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
T cells compete for access to antigen-bearing antigen-presenting cells
RM Kedl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
T cell vaccination in mice with invasive pulmonary aspergillosis
E Cenci et al.
JOURNAL OF IMMUNOLOGY (2000)
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease:: prophylactic infusion of EBV-specific cytotoxic T cells
Å Gustafsson et al.
BLOOD (2000)
Share Paper
